A resident T cell population producing IL-17 and GM-CSF, termed ﻿tissue-resident memory-like Th17 cells (TRM17 cells), have been identified in the BAL from COVID-19 patients 3 weeks post symptom on-set [84] (Fig. 4). Here, CSF2 is linked to COVID-19.